SuperworthStaar Surgical profit margin STAA
Gross, operating and net profit as a share of revenue over the last twelve months, from 2010.
- Net margin, 12 months
- 1.1%
- Operating margin, 12 months
- 4.0%
- Net margin on a year earlier
- +43.6 pts
- Peer median
- 8.2%
Over the twelve months to Jul 3, 2026, Staar Surgical kept 1.1% of its revenue as net profit, with an operating margin of 4.0% and a gross margin of 76.6%.
Five years earlier its net margin was 10.1%.
The median for 10 medical instruments and supplies stocks of a similar size is 8.2%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −33.6% | −38.3% | 76.2% |
| FY2024 | −6.4% | −4.0% | 76.3% |
| FY2023 | 6.6% | 8.7% | 78.4% |
| FY2022 | 13.6% | 15.4% | 78.5% |
| FY2021 | 10.6% | 14.5% | 77.5% |
| FY2020 | 3.6% | 4.1% | 72.4% |
| FY2019 | 9.4% | 7.9% | 74.5% |
| FY2018 | 4.0% | 5.3% | 73.8% |
| FY2017 | −2.4% | −4.0% | 70.9% |
| FY2016 | −14.7% | −15.4% | 70.8% |
| FY2015 | −8.5% | −6.9% | 68.4% |
| FY2014 | −11.2% | −10.7% | 65.1% |
| FY2013 | 0.6% | 1.0% | 69.7% |
| FY2012 | −2.8% | −1.9% | 69.4% |
| FY2011 | 2.1% | 4.4% | 67.5% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 1.1% | +43.6 pts | 4.0% | |
| Q1 FY26 | −7.2% | +18.2 pts | −9.1% | |
| Q4 FY25 | −33.6% | −27.2 pts | −38.3% | |
| Q3 FY25 | −41.8% | −48.2 pts | −42.0% | |
| Q2 FY25 | −42.4% | −47.4 pts | −48.8% | |
| Q1 FY25 | −25.5% | −30.2 pts | −24.3% | |
| Q4 FY24 | −6.4% | −13.1 pts | −4.0% | |
| Q3 FY24 | 6.4% | +0.1 pts | 7.5% | |
| Q2 FY24 | 5.0% | −3.1 pts | 7.9% | |
| Q1 FY24 | 4.7% | −6.1 pts | 7.1% | |
| Q4 FY23 | 6.6% | −7.0 pts | 8.7% | |
| Q3 FY23 | 6.3% | −7.3 pts | 6.0% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Staar Surgical's size, closest first, today.
| Company | Profit margin |
|---|---|
| STAAStaar Surgical | 1.1% |
| IRMDIradimed | 26.7% |
| BVSBioventus | 9.4% |
| CDRECadre | 5.3% |
| EYENational Vision | 2.5% |
| MOVMovado | 6.0% |
| LMATLemaitre Vascular | 25.0% |
| INSPInspire Medical Systems | 15.0% |
| MDXGMimedx | 1.8% |
| UFPTUFP Technologies | 11.4% |
| TCMDTactile Systems Technology | 7.1% |
| Peer median | 8.2% |
Where Staar Surgical ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Staar Surgical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.